NYBC Ventures

Description

NYBC Ventures, a part of New York Blood Center Enterprises, is a venture fund dedicated to accelerating innovation in blood-related fields and cellular therapies and technology. NYBC established the fund with a $50M investment and a mission to improve patients’ lives by advancing therapeutics, enabling platforms and technologies, and driving collaborations to further NYBC’s impact. We invest in mission-driven therapeutics, devices, and innovative technologies, addressing the most pressing challenges in our area of focus: cell therapy, transfusion medicine, infectious diseases, and benign hematology. Visit our website to learn more and connect with us! Or connect with us through LinkedIn.

Keywords venture fund, cellular therapies, blood research, research discovery, investment fund.